Statistics on Biotechnology Use  
Results by fields of operation
Business Sector Biotechnology indicators by relevance of biotechnology to company activity.
Unidades: specified in variables

;Total;Main;Secondary dwellings;Tool;
Companies that carry out R&D in Biotechnology;1.299;559;230;510;
%Companies according to biotechnology used: Genetic code;30,8;39,2;31,4;21,3;
%Companies according to biotechnology used: Functional units;38,4;45,7;43;28,3;
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;21,5;26,3;19,8;17,1;
%Companies according to biotechnology used: Bioprocesses;50,8;40,7;54,3;60,2;
%Companies according to biotechnology used: Sub-cellular organisms;8,5;12,7;4,6;5,6;
%Companies according to biotechnology used: Bio-computing;24;34,7;22,1;13,2;
%Companies according to biotechnology used: Nanobiotechnology;12,1;15,6;15,6;6,6;
%Companies according to biotechnology used: Other;16,9;19,2;20,6;12,7;
%Company by field(s) of ultimate application of biotechnology use: Human Health;45,5;64,2;36,9;28,8;
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;15,5;17,4;16;13,1;
%Company by field(s) of ultimate application of biotechnology use: Food products;32,3;21;34,5;43,8;
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;23,8;20,7;30,9;23,9;
%Company by field(s) of ultimate application of biotechnology use: Environment;15,6;14,1;24;13,5;
%Company by field(s) of ultimate application of biotechnology use: Industry;13,7;14,7;18,5;10,6;
Personnel in R&D in biotechnology (no. of persons);15.750;6.759;3.644;5.347;
Personnel in R&D in biotechnology (no. of persons): Research personnel;8.379;3.802;2.145;2.433;
Personnel in R&D in biotechnology (no. of persons): Technical and auxiliary personnel;7.371;2.957;1.500;2.914;
Personnel in R&D in biotechnology (no. of persons). Women;8.711;3.890;2.040;2.782;
Personnel in R&D in biotechnology (no. of persons). Women: Research personnel;4.510;2.078;1.196;1.236;
Personnel in R&D in biotechnology (no. of persons). Women: Technical and auxiliary personnel;4.200;1.811;843;1.546;
Personnel in R&D in biotechnology (FTE);11.528,6;5.389;2.417,3;3.722,4;
Personnel in R&D in biotechnology (FTE): Research personnel;6.342,7;3.157;1.493,6;1.692,1;
Personnel in R&D in biotechnology (FTE): Technical and auxiliary personnel;5.185,9;2.232;923,7;2.030,3;
Personnel in R&D in biotechnology (FTE). Women;6.539,7;3.168,1;1.378,1;1.993,6;
Personnel in R&D in biotechnology (FTE). Women: Research personnel;3.455,7;1.734,1;839,4;882,2;
Personnel in R&D in biotechnology (FTE). Women: Technical and auxiliary personnel;3.084;1.434;538,7;1.111,4;
Internal expenditure on R&D (thousands of euros);1.038.582;519.104;204.849;314.630;
1) By nature of the expense: Current expenses;940.091;466.051;179.259;294.780;
1.1) Remuneration to research personnel;321.570;164.629;73.301;83.640;
1.2) Remuneration to technicians and auxiliary personnel;194.836;85.747;33.173;75.916;
1.3) Other current expenses;423.685;215.675;72.786;135.225;
2) By nature of the expense: Capital expenses;98.492;53.052;25.589;19.850;
2.1) Land and buildings;10.199;5.434;2.616;2.149;
2.2) Equipment and instruments;72.584;36.725;20.086;15.773;
2.3) Acquisition of specific R+D software;5.721;2.513;2.103;1.104;
2.4) Otros productos de propiedad intelectual específicos para I+D;9.987;8.379;784;823;
1.1) By origin of the funds: Own funds;711.488;314.308;155.688;241.492;
1.2) By origin of the funds: From companies;121.738;80.154;10.983;30.601;
1.3) By origin of the funds: Public Administration funds;107.477;61.083;16.108;30.285;
1.4) By origin of the funds: From Universities;192;68;14;111;
1.5) By origin of the funds: From non profit private institutions;10.756;9.444;0;1.312;
1.6) By origin of the funds: Foreign funds;86.931;54.046;22.055;10.829;
Purchase of R&D services in biotechnology (thousands of euros);145.557;105.405;16.127;24.025;
Purchase of R&D services in biotechnology (thousands of euros): In Spain;95.915;74.486;14.004;7.425;
Purchase of R&D services in biotechnology (thousands of euros): Abroad;49.642;30.919;2.123;16.600;
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;40,2;49,4;39,8;30,4;
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;13,2;12,5;15,9;12,7;
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;19;21,5;20;15,7;
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;11,5;10,4;15,1;11,1;
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;15,9;16,1;23,5;12,1;
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels;17;20,6;19,3;11,9;
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;16,4;16,3;23,1;13,6;
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;40,5;46,9;44,1;31,9;
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;55;65,2;55,1;43,8;
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;21,9;24,5;25;17,6;
% Companies with income of an international origin related to biotechnological activities;23,5;33,3;19,8;14,4;
% Turnover representing income of an international origin related to biotechnological activities;1,9;12,1;1,2;1,3;
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU;61,6;44;79,9;60,4;
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries;38,4;56;20,1;39,6;
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services;87,6;97;73,4;96,5;
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;10,9;1,5;25,9;0,9;
% Income of an international origin related with activities according to the classification: Operating source abroad;1,1;1,3;0,7;1,3;
% Income of an international origin related with activities according to the classification: Other;0,4;0,2;0;1,3;
Notas:
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute